rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 130

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-14882 · 2026

Do GLP-1 Drugs Help After Bariatric Surgery? Systematic Review and Meta-Analysis

GLP-1 RAs post-bariatric surgery promoted additional weight loss and improved metabolic markers including BMI, cholesterol, triglycerides, fasting glucose, blood pressure, and HbA1c compared to placebo.

Bilal, Abdur Rafay; Ibrahim, Muhammad; Arfin, S M Washaqul; Bilal, Abdur Raheem; Balach, Rahul; Qureshi, Shaheer; Gaba, Hateem; Collins, Peter; Ahmed, Raheel; Waqas, Saad Ahmed ·

RPEP-14883 · 2026

Antimicrobial Peptide Wound Dressings Use Light to Kill Resistant Bacteria

GelMA hydrogels combining antimicrobial peptide TetraF2W-RR with photosensitizer Chlorin e6 showed enhanced antibiofilm activity via photodynamic therapy, with immobilization strategy affecting efficacy.

Bilgiç, Eda; Çelebi, Nisa Nilsu; Avşar, Nermin Topaloğlu; Karaman, Didem Şen; Pulat, Günnur ·

RPEP-14885 · 2026

GLP-1 Drugs Show Anti-Inflammatory Promise for Autoimmune Diseases

GLP-1 RAs demonstrated anti-inflammatory effects in patients with immune-mediated inflammatory disorders, though significant heterogeneity prevented meta-analysis.

Birda, Chhagan L; Ibrahim, Fadwa; Chatterjee, Abhirup; Jena, Anuraag; Sharma, Vishal; Sebastian, Shaji ·

RPEP-14887 · 2026

Tirzepatide Reverses Fat Tissue Damage in Obese Diabetic Mice Lacking Estrogen

Tirzepatide (10 nmol/kg/day for 4 weeks) reversed brown adipose tissue whitening, reduced inflammation, and restored mitochondrial function in ovariectomized obese diabetic mice.

Bittencourt, Julie Oliveira A; Marcondes-de-Castro, Ilitch A; Marinho, Thatiany Souza; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto ·

RPEP-14889 · 2026

How the Migraine Drug Ubrogepant Is Processed and Eliminated by the Body

Mean total radioactivity recovery was 92.4% after a single 50 mg oral dose of [14C]-ubrogepant, with the drug undergoing extensive hepatic metabolism.

Boinpally, Ramesh R; Rowe, Joshua; Chandrasekar, Pushpa; White, Rebecca B; Marcantonio, Eugene E; Trainor, Nicole; Liang, Yuexia; Maciolek, Cheri; Small, James H; Houle, Robert; Hafey, Michael J; Xie, Huizhi; Yabut, Jocelyn; Fandozzi, Christine ·

RPEP-14890 · 2026

Semaglutide Plus Metformin Improves Weight and Fertility in Obese PCOS Patients

Subcutaneous semaglutide combined with metformin produced significant weight loss and improved fertility outcomes in 20 consecutive PCOS patients with obesity and prediabetes.

Bolek, Tomáš; Turňová, Petra; Janošova, Svetlana; Péč, Martin Jozef; Ságová, Ivana; Nagy, Norbert; Jurica, Jakub; Mokáň, Marián; Samoš, Matej ·

RPEP-14891 · 2026

Lab-Designed Peptides Block Dangerous Candida Fungal Biofilms Without Killing Cells

Phage display-derived neutralizing AMPs (nAMPs) effectively inhibited biofilm formation by C. albicans, C. auris, and C. parapsilosis through modulation of pathogenic behavior rather than cell killing.

Bolotnikov, Grigory; Gruber, Daniel; Walter, Jan-Christoph; Kühnel, Kim; Kemal, Turgay; Rodriguez, Armando; Preising, Nico; Ständker, Ludger; Firacative, Carolina; Spellerberg, Barbara; Stenger, Steffen; Rosenau, Frank; Kissmann, Ann-Kathrin ·

RPEP-14893 · 2026

GLP-1 Drugs Linked to Lower Death Risk After Diabetic Foot Ulcers

GLP-1 RA use was associated with reduced 1-year mortality following first diabetic foot ulcer in a nationwide French cohort, with secondary analysis also examining mortality after major lower-limb amputation.

Bonnet, Jean-Baptiste; Huguet, Helena; Avignon, Antoine; Duflos, Claire; Sultan, Ariane ·

RPEP-14894 · 2026

Tree Root Peptides That Help Beneficial Fungi Form Symbiotic Partnerships

Genome-wide analysis identified poplar CLE peptides that promote ectomycorrhizal symbiosis, revealing plant small secreted peptide roles in tree-fungus association.

Bonnot, Clémence; Morin, Emmanuelle; Da Silva Machado, Emilie; Veneault-Fourrey, Claire; Kohler, Annegret; Martin, Francis ·

RPEP-14895 · 2026

Inflammation Patterns in Heart Failure Differ by How Well the Heart Pumps

Systemic inflammation in HFpEF is linked to cardiovascular-kidney-metabolic conditions, while HFrEF inflammation develops secondary to cardiac stress, with distinct patterns across the ejection fraction spectrum.

Borlaug, Barry A; Holse, Cecilie; Jung, Mette Holme; Lincoff, A Michael; Mulvagh, Sharon L; Stærk-Østergaard, Jacob; Tuttle, Katherine R; Petrie, Mark C ·

RPEP-14896 · 2026

GIP Receptor Signaling Reduces Nausea Side Effects of Weight Loss Peptide PYY

GIP receptor signaling modulates PYY-induced appetite suppression and reduces associated nausea and malaise in rodents, suggesting a mechanism for improved tolerability in multi-agonist obesity drugs.

Borner, Tito; Pataro, Allison M; Curtis, Genevieve R; Alonso, Brandon; Hu, Jiayin; Fortin, Samantha M; Koul-Tiwari, Richa; Hughes, Emily; Kong, Jimmy X; Jordan, Emily; Barnes, Robert; Bernardo, Barbara; Gardner, Maxwell; Ma, Wenzhe; Gosset, James R; Esquejo, Ryan M; Fortin, Jean-Philippe; De Jonghe, Bart C; Bence, Kendra K; Hayes, Matthew R ·

RPEP-14897 · 2026

Growing Insulin and GLP-1 Drugs in Plants and Algae to Make Them Affordable

Plant- and microalgae-based biotechnological platforms offer affordable production and non-invasive (oral) delivery strategies for antidiabetic peptides including insulin and GLP-1 RAs.

Boscart, Thibault; Barras, Alexandre; Plaisance, Valérie; Pawlowski, Valérie; Giovanelli, Emerson; Bardor, Muriel; D'Hulst, Christophe; Abderrahmani, Amar ·

RPEP-14900 · 2026

AI Is Transforming How We Discover New Antibiotics and Antimicrobial Peptides

AI approaches including predictive models and de novo generative design are accelerating antimicrobial and antimicrobial peptide discovery, offering a transformative response to the global resistance crisis.

Boudza, Romaisaa; Bounou, Salim; Segura-Garcia, Jaume; Moukadiri, Ismail; Maicas, Sergi ·

RPEP-14902 · 2026

Medicare Patients Stay on GLP-1 Drugs Longer Than SGLT-2 Inhibitors

GLP-1 RA initiators showed higher treatment persistence compared to SGLT2i initiators among Medicare Advantage beneficiaries with T2DM, including subgroups with cardiovascular disease and obesity.

Bowe, Andy; Hayes, Mary; John, Isha; Diaz, Monica; Dixon, Suzanne; Poonawalla, Insiya ·

RPEP-14904 · 2026

Severe GI Bleeding After Radioactive Peptide Therapy for Intestinal Cancer

Three cycles of 177Lu-DOTATATE PRRT for small intestine neuroendocrine tumor led to recurrent GI bleeding requiring four ICU admissions, 14 packed cell transfusions, and eventual surgery.

Brackenier, C; Leupe, H; Dekervel, J; Verslype, C; De Hertogh, G; Topal, H; Rasschaert, G; Deroose, C M; Van Herpe, F ·

RPEP-14906 · 2026

Semaglutide Preserves Muscle Mass and Metabolic Rate Better Than Dieting Alone in Obese Minipigs

Semaglutide treatment preserved fat-free mass and energy expenditure compared to diet restriction alone in obese minipigs, demonstrating more favorable body composition changes.

Bredum, Simon Krogh; Jacobsen, Julie M; Halling, Jens Frey; Blom, Ida; Lewis, Christopher T A; Ochala, Julien; Fredholm, Merete; Lundh, Sofia; Schmücker, Malte; Ozenne, Brice; Domingos, Ana I; Hald, Bjørn Olav; Larsen, Steen; Cirera, Susanna; Christoffersen, Berit Oestergaard ·

RPEP-14909 · 2026

Bariatric Surgery vs GLP-1 Drugs Over 3 Years in Medicare and Medicaid Patients

Three-year comparison of bariatric surgery versus GLP-1 RAs in Medicare and Medicaid patients with diabetes provides real-world effectiveness data in a publicly insured population.

Brown, Avery; Patel, Suhani S; Li, Elizabeth; Vu, Alexander Hien; Somoza, Eduardo; Chen, Jialin; Zhang, Donglan; Massie, Allan B; Orandi, Babak J; Segev, Dorry; Parikh, Manish; Chhabra, Karan ·

RPEP-14911 · 2026

NLRP3 Inflammasome Blocker Reduces Weight, Blood Sugar, and Fatty Liver in Obese Mice

VTX3232 NLRP3 inhibition reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice by tempering metabolic inflammation.

Bultinck, Jennyfer; Yuan, Shendong; Cantuti-Castelvetri, Ludovico; Brosens, Lander; Bracke, Debby; Collins, James; Goethals, Jens; Christianson, Christina; Nuss, John; Ogilvie, Kathleen ·

RPEP-14912 · 2026

How Streptococcus Bacteria Resist Our Natural Antimicrobial Defenses

S protein coordinates cell wall modification and repair in Streptococcus to resist host-derived antimicrobial peptides, revealing a key bacterial defense mechanism against innate immunity.

Burnier, Jessica; Gallay, Clement; Bruce, Kevin E; Bjånes, Elisabet; Martin, Louise; Jim, Kin Ki; Tsui, Ho-Ching Tiffany; Cremers, Amelieke J H; Mignolet, Johann; Vollmer, Daniela; Biboy, Jacob; Nizet, Victor; Vollmer, Waldemar; Winkler, Malcolm E; Veening, Jan-Willem ·

RPEP-14914 · 2026

Real-World Experience with Anti-CGRP Migraine Antibodies in Large US Health Plan

Real-world data from a large US healthcare plan demonstrates treatment persistence patterns and patient satisfaction with self-injectable anti-CGRP monoclonal antibodies for migraine prevention.

Buse, Dawn C; Lipton, Richard B; Urman, Robert; Vaidya, Shruti J; Robinson, Sarah C; Jacobson, Alice S; Scott, Alexandra B; Bensink, Mark E; Pressman, Alice R ·

RPEP-14915 · 2026

Virus-Inspired Peptides Help Nanoparticles Cross the Blood-Brain Barrier

AAV9-derived peptides (AAV.PHP.eB, AAV.X1, AAV.CPP.16) grafted onto nanoparticles synergized with electroporation to enhance BBB transport beyond either approach alone.

Butkovich, Nina; Xu, Yifei; Song, Yuchen; Wang, Lu; Ramirez, Aaron; Li, Enya; Siao, Nikhil Tien Chi; Velazquez-Rivera, Eric; Xiang, Liangzhong; Xu, Xiangmin; Wang, Szu-Wen ·

RPEP-14917 · 2026

Physical Activity Improves Gut Hormone Sensitivity and Appetite Control in Mice

Physical activity promotes gut structural adaptation, enhanced nutrient sensing, and increased sensitivity to appetite-regulating gut peptides in mice.

Bæch-Laursen, Cecilie; Ucin, Jon Vergara; Galsgaard, Katrine Douglas; Llana, Jesus; Kissow, Hannelouise; Rehfeld, Jens Frederik; Holst, Jens Juul; Pedersen, Bente Klarlund; Sanchis, Paula ·

RPEP-14918 · 2026

Antimicrobial Peptides in Cervical Cancer: Both Fighting and Fueling Tumors

AMPs exhibit dual roles in cervical carcinogenesis — both anti-tumorigenic and pro-tumorigenic effects — requiring careful characterization before therapeutic development.

Błażejczyk, Idalia; Daniluk, Tamara; Toczyłowski, Kacper; Gorbacz-Konończuk, Joanna; Wnorowska, Urszula; Bucki, Robert; Piktel, Ewelina ·

RPEP-14919 · 2026

Mapping Appetite Hormones Ghrelin and CCK Along the Fish Gut

Spatiotemporal characterization revealed distinct ghrelin and CCK distribution patterns along the juvenile seabream GIT, with levels responding to feeding status and diet composition.

Caderno, Anyell; Tang, Patrik; de Las Heras, Verónica; Gharbi, Naouel; Alarcón-López, Francisco Javier; Mancera, Juan Miguel; Martos-Sitcha, Juan Antonio; Gilannejad, Neda ·

RPEP-14920 · 2026

Machine Learning Platform Mines Animal Venom Peptides for Rapid Drug Discovery

A machine learning-enabled venom peptide platform rapidly identifies and optimizes disulfide-stabilized venom peptides targeting GPCRs and ion channels for pharmaceutical development.

Cai, Fei; Zhou, Lijuan; Delgado, Bryce; Chang, Wenping; Tom, Jeffrey; Hernandez, Evelyn; Joshi, Prajakta; Song, Aimin; Masureel, Matthieu; Maun, Henry R; Chang, Andrew; Zhang, Yingnan ·

RPEP-14921 · 2026

GLP-1 Drugs Linked to Reduced Substance Use Disorders in US Veterans

GLP-1 RA initiation was associated with reduced incidence of alcohol, cannabis, cocaine, nicotine, opioid, and other SUDs in veterans without prior addictions, and reduced adverse outcomes in those with pre-existing SUDs.

Cai, Miao; Choi, Taeyoung; Xie, Yan; Al-Aly, Ziyad ·

RPEP-14922 · 2026

How Diabetes Patients Perceive Insulin Therapy Across Disease Types

Insulin therapy perceptions differ significantly between type 1, type 2, and prediabetic patients, with negative perceptions common across groups and potentially delaying treatment.

Cakir, Ahmet; Memis, Hasan; Ozdemir-Ayduran, Nesligül; Tarin, Serenay; Evren, Bahri ·

RPEP-14924 · 2026

GLP-1 Drugs for Obese Heart Failure Patients: Comprehensive Meta-Analysis

Comprehensive meta-analysis of RCTs and propensity-matched cohorts demonstrates GLP-1 RA efficacy in obese HFpEF patients, with benefits including weight loss and anti-inflammatory effects.

Caldeira Gaelzer, Giulia; Armani Prata, Alonzo; Gustavo Rizzolli, Luís; Mendes Afonso, Luisalice; Lenci Marques, Gustavo ·

RPEP-14925 · 2026

Vitamin D's Role in Fighting COVID-19, Long COVID, and Influenza

Vitamin D modulates infectious disease outcomes through antimicrobial peptide induction (cathelicidin/LL-37), immune regulation, and anti-inflammatory effects in COVID-19, Long COVID, and influenza.

Caliman-Sturdza, Olga Adriana; Gheorghita, Roxana Elena; Soldanescu, Iuliana; Dimian, Mihai; Mangul, Serghei ·

RPEP-14926 · 2026

How NPY Blocks Vagal Gut-Brain Appetite Signals in the Brainstem

NPY inhibits vagal activation of NTS catecholamine neurons via presynaptic Y2 receptors, providing a mechanism by which NPY modulates gut-derived satiety signaling in the brainstem.

Calkins, Rowan J; Zhao, Huan; Page, Stephen J; Neyens, Drew M; Appleyard, Suzanne M ·

RPEP-14927 · 2026

GLP-1 Drugs Do Not Increase Pancreatitis Risk in High-Risk Diabetes Patients

GLP-1 analogues were not associated with increased recurrent pancreatitis risk in diabetic patients with prior pancreatitis or elevated lipase, in a cohort of >4.5 million members.

Calvarysky, Bronya; Gal, Yaara; Kushnir, Shiri; Turjeman, Adi; Shochat, Tzippy; Dotan, Idit; Diker Cohen, Talia ·

RPEP-14930 · 2026

People Born Without Growth Hormone Have Unique IGF-1 Patterns and Avoid Heart Disease

Congenital isolated GH-deficient individuals show severely reduced IGF-I and IGFBP-3 but altered IGF-I bioavailability, associated with no premature atherosclerosis and normal lifespan despite metabolic risk factors.

Campos, Viviane C; Aguiar Oliveira, Manuel H; Bidlingmaier, Martin; Yuen, Kevin C J; Salvatori, Roberto; Oliveira, Carla R P; Leal, Angela; Melo, Enaldo; Schilbach, Katharina; Frystyk, Jan; Schweizer, Júnia R O L ·

RPEP-14931 · 2026

Genetic Variants in the GLP-1 Receptor Affect How Well Oral Semaglutide Works

GLP1R polymorphisms rs6923761 and rs761387 significantly influenced clinical response to oral semaglutide in a retrospective cohort of T2DM patients.

Candido, Riccardo; Toffoli, Barbara; Baccichetto, Gabriele; Marchese, Francesca; Carpenè, Silvia; Gaiotti, Sara; Fabris, Bruno; Bernardi, Stella ·